{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:10:16Z","timestamp":1793337016852,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T00:00:00Z","timestamp":1715558400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Down syndrome (DS) is a genetic disease characterized by a supernumerary chromosome 21. Intellectual deficiency (ID) is one of the most prominent features of DS. Central nervous system defects lead to learning disabilities, motor and language delays, and memory impairments. At present, a prenatal treatment for the ID in DS is lacking. Subcutaneous administration of synthetic preimplantation factor (sPIF, a peptide with a range of biological functions) in a model of severe brain damage has shown neuroprotective and anti-inflammatory properties by directly targeting neurons and microglia. Here, we evaluated the effect of PIF administration during gestation and until weaning on Dp(16)1Yey mice (a mouse model of DS). Possible effects at the juvenile stage were assessed using behavioral tests and molecular and histological analyses of the brain. To test the influence of perinatal sPIF treatment at the adult stage, hippocampus-dependent memory was evaluated on postnatal day 90. Dp(16)1Yey pups showed significant behavioral impairment, with impaired neurogenesis, microglial cell activation and a low microglial cell count, and the deregulated expression of genes linked to neuroinflammation and cell cycle regulation. Treatment with sPIF restored early postnatal hippocampal neurogenesis, with beneficial effects on astrocytes, microglia, inflammation, and cell cycle markers. Moreover, treatment with sPIF restored the level of DYRK1A, a protein that is involved in cognitive impairments in DS. In line with the beneficial effects on neurogenesis, perinatal treatment with sPIF was associated with an improvement in working memory in adult Dp(16)1Yey mice. Perinatal treatment with sPIF might be an option for mitigating cognitive impairments in people with DS.<\/jats:p>","DOI":"10.1007\/s00018-024-05245-9","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:02:03Z","timestamp":1715594523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prenatal treatment with preimplantation factor improves early postnatal neurogenesis and cognitive impairments in a mouse model of Down syndrome"],"prefix":"10.1007","volume":"81","author":[{"given":"Manon","family":"Moreau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolphe","family":"Dard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lia","family":"Madani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janany","family":"Kandiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadim","family":"Kassis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Ziga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lo\u00efse","family":"Castiglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solenn","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Matrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Vialard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4746-8941","authenticated-orcid":false,"given":"Nathalie","family":"Janel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,13]]},"reference":[{"key":"5245_CR1","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1177\/088307380101600610","volume":"16","author":"R Seidl","year":"2001","unstructured":"Seidl R, Bidmon B, Bajo M et al (2001) Evidence for apoptosis in the fetal down syndrome brain. J Child Neurol 16:438\u2013442. https:\/\/doi.org\/10.1177\/088307380101600610","journal-title":"J Child Neurol"},{"key":"5245_CR2","doi-asserted-by":"publisher","first-page":"11483","DOI":"10.1523\/JNEUROSCI.3406-07.2007","volume":"27","author":"L Chakrabarti","year":"2007","unstructured":"Chakrabarti L, Galdzicki Z, Haydar TF (2007) Defects in embryonic neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse model of Down syndrome. J Neurosci 27:11483\u201311495. https:\/\/doi.org\/10.1523\/JNEUROSCI.3406-07.2007","journal-title":"J Neurosci"},{"key":"5245_CR3","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1093\/cercor\/bhp176","volume":"20","author":"K Ishihara","year":"2010","unstructured":"Ishihara K, Amano K, Takaki E et al (2010) Enlarged brain ventricles and impaired neurogenesis in the Ts1Cje and Ts2Cje mouse models of Down syndrome. Cereb Cortex 20:1131\u20131143. https:\/\/doi.org\/10.1093\/cercor\/bhp176","journal-title":"Cereb Cortex"},{"key":"5245_CR4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/j.1750-3639.2007.00113.x","volume":"18","author":"S Guidi","year":"2008","unstructured":"Guidi S, Bonasoni P, Ceccarelli C et al (2008) Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome. Brain Pathol 18:180\u2013197. https:\/\/doi.org\/10.1111\/j.1750-3639.2007.00113.x","journal-title":"Brain Pathol"},{"key":"5245_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.aanat.2008.05.007","volume":"190","author":"KB Larsen","year":"2008","unstructured":"Larsen KB, Laursen H, Graem N et al (2008) Reduced cell number in the neocortical part of the human fetal brain in Down syndrome. Ann Anat 190:421\u2013427. https:\/\/doi.org\/10.1016\/j.aanat.2008.05.007","journal-title":"Ann Anat"},{"key":"5245_CR6","first-page":"181","volume":"9","author":"B Schmidt-Sidor","year":"1990","unstructured":"Schmidt-Sidor B, Wisniewski KE, Shepard TH, Sersen EA (1990) Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months. Clin Neuropathol 9:181\u2013190","journal-title":"Clin Neuropathol"},{"key":"5245_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/ajmg.1320370755","volume":"7","author":"KE Wisniewski","year":"1990","unstructured":"Wisniewski KE (1990) Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis. Am J Med Genet Suppl 7:274\u2013281. https:\/\/doi.org\/10.1002\/ajmg.1320370755","journal-title":"Am J Med Genet Suppl"},{"key":"5245_CR8","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1016\/j.gim.2022.06.011","volume":"24","author":"C Cieuta-Walti","year":"2022","unstructured":"Cieuta-Walti C, Cuenca-Royo A, Langohr K et al (2022) Safety and preliminary efficacy on cognitive performance and adaptive functionality of epigallocatechin gallate (EGCG) in children with Down syndrome. A randomized phase ib clinical trial (PERSEUS study). Genet Med 24:2004\u20132013. https:\/\/doi.org\/10.1016\/j.gim.2022.06.011","journal-title":"Genet Med"},{"key":"5245_CR9","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/S1474-4422(16)30034-5","volume":"15","author":"R de la Torre","year":"2016","unstructured":"de la Torre R, de Sola S, Hernandez G et al (2016) Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down\u2019s syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Neurol 15:801\u2013810. https:\/\/doi.org\/10.1016\/S1474-4422(16)30034-5","journal-title":"Lancet Neurol"},{"key":"5245_CR10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/mnfr.201300325","volume":"58","author":"R De la Torre","year":"2014","unstructured":"De la Torre R, De Sola S, Pons M et al (2014) Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans. Mol Nutr Food Res 58:278\u2013288. https:\/\/doi.org\/10.1002\/mnfr.201300325","journal-title":"Mol Nutr Food Res"},{"key":"5245_CR11","doi-asserted-by":"publisher","first-page":"eabq4515","DOI":"10.1126\/science.abq4515","volume":"377","author":"M Manfredi-Lozano","year":"2022","unstructured":"Manfredi-Lozano M, Leysen V, Adamo M et al (2022) GnRH replacement rescues cognition in Down syndrome. Science 377:eabq4515. https:\/\/doi.org\/10.1126\/science.abq4515","journal-title":"Science"},{"key":"5245_CR12","doi-asserted-by":"publisher","first-page":"e100263","DOI":"10.1371\/journal.pone.0100263","volume":"9","author":"ER Barnea","year":"2014","unstructured":"Barnea ER, Lubman DM, Liu Y-H et al (2014) Insight into PreImplantation factor (PIF*) mechanism for embryo protection and development: target oxidative stress and protein misfolding (PDI and HSP) through essential RIKP [corrected] binding site. PLoS ONE 9:e100263. https:\/\/doi.org\/10.1371\/journal.pone.0100263","journal-title":"PLoS ONE"},{"key":"5245_CR13","doi-asserted-by":"publisher","first-page":"e0180642","DOI":"10.1371\/journal.pone.0180642","volume":"12","author":"N Di Simone","year":"2017","unstructured":"Di Simone N, Di Nicuolo F, Marana R et al (2017) Synthetic PreImplantation factor (PIF) prevents fetal loss by modulating LPS induced inflammatory response. PLoS ONE 12:e0180642. https:\/\/doi.org\/10.1371\/journal.pone.0180642","journal-title":"PLoS ONE"},{"key":"5245_CR14","doi-asserted-by":"publisher","first-page":"e2504","DOI":"10.1038\/cddis.2016.382","volume":"7","author":"H Moindjie","year":"2016","unstructured":"Moindjie H, Santos ED, Gouesse R-J et al (2016) Preimplantation factor is an anti-apoptotic effector in human trophoblasts involving p53 signaling pathway. Cell Death Dis 7:e2504. https:\/\/doi.org\/10.1038\/cddis.2016.382","journal-title":"Cell Death Dis"},{"key":"5245_CR15","doi-asserted-by":"publisher","first-page":"459e1","DOI":"10.1016\/j.ajog.2010.03.024","volume":"202","author":"MJ Paidas","year":"2010","unstructured":"Paidas MJ, Krikun G, Huang SJ et al (2010) A genomic and proteomic investigation of the impact of preimplantation factor on human decidual cells. Am J Obstet Gynecol 202:459e1\u2013459e8. https:\/\/doi.org\/10.1016\/j.ajog.2010.03.024","journal-title":"Am J Obstet Gynecol"},{"key":"5245_CR16","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1038\/cdd.2015.55","volume":"22","author":"M Mueller","year":"2015","unstructured":"Mueller M, Schoeberlein A, Zhou J et al (2015) PreImplantation factor bolsters neuroprotection via modulating protein kinase A and protein kinase C signaling. Cell Death Differ 22:2078\u20132086. https:\/\/doi.org\/10.1038\/cdd.2015.55","journal-title":"Cell Death Differ"},{"key":"5245_CR17","doi-asserted-by":"publisher","first-page":"13882","DOI":"10.1073\/pnas.1411674111","volume":"111","author":"M Mueller","year":"2014","unstructured":"Mueller M, Zhou J, Yang L et al (2014) PreImplantation factor promotes neuroprotection by targeting microRNA let-7. Proc Natl Acad Sci U S A 111:13882\u201313887. https:\/\/doi.org\/10.1073\/pnas.1411674111","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5245_CR18","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.pharmthera.2015.10.008","volume":"156","author":"ER Barnea","year":"2015","unstructured":"Barnea ER, Almogi-Hazan O, Or R et al (2015) Immune regulatory and neuroprotective properties of preimplantation factor: from newborn to adult. Pharmacol Ther 156:10\u201325. https:\/\/doi.org\/10.1016\/j.pharmthera.2015.10.008","journal-title":"Pharmacol Ther"},{"key":"5245_CR19","doi-asserted-by":"publisher","first-page":"21834","DOI":"10.18632\/oncotarget.15662","volume":"8","author":"G Migliara","year":"2017","unstructured":"Migliara G, Mueller M, Piermattei A et al (2017) PIF* promotes brain re-myelination locally while regulating systemic inflammation- clinically relevant multiple sclerosis M.smegmatis model. Oncotarget 8:21834\u201321851. https:\/\/doi.org\/10.18632\/oncotarget.15662","journal-title":"Oncotarget"},{"key":"5245_CR20","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1093\/hmg\/ddm086","volume":"16","author":"Z Li","year":"2007","unstructured":"Li Z, Yu T, Morishima M et al (2007) Duplication of the entire 22.9\u00a0mb human chromosome 21 syntenic region on mouse chromosome 16 causes cardiovascular and gastrointestinal abnormalities. Hum Mol Genet 16:1359\u20131366. https:\/\/doi.org\/10.1093\/hmg\/ddm086","journal-title":"Hum Mol Genet"},{"key":"5245_CR21","doi-asserted-by":"publisher","first-page":"735920","DOI":"10.3389\/fnbeh.2021.735920","volume":"15","author":"F de Chaumont","year":"2021","unstructured":"de Chaumont F, Lemi\u00e8re N, Coqueran S et al (2021) LMT USV Toolbox, a Novel Methodological Approach to Place Mouse Ultrasonic vocalizations in their behavioral Contexts\u2014A study in female and male C57BL\/6J mice and in Shank3 mutant females. Front Behav Neurosci 15:735920. https:\/\/doi.org\/10.3389\/fnbeh.2021.735920","journal-title":"Front Behav Neurosci"},{"key":"5245_CR22","doi-asserted-by":"publisher","first-page":"e1009777","DOI":"10.1371\/journal.pgen.1009777","volume":"17","author":"V Brault","year":"2021","unstructured":"Brault V, Nguyen TL, Flores-Guti\u00e9rrez J et al (2021) Dyrk1a gene dosage in glutamatergic neurons has key effects in cognitive deficits observed in mouse models of MRD7 and Down syndrome. PLoS Genet 17:e1009777. https:\/\/doi.org\/10.1371\/journal.pgen.1009777","journal-title":"PLoS Genet"},{"key":"5245_CR23","doi-asserted-by":"publisher","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","volume":"29","author":"MW Pfaffl","year":"2001","unstructured":"Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45. https:\/\/doi.org\/10.1093\/nar\/29.9.e45","journal-title":"Nucleic Acids Res"},{"key":"5245_CR24","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1523\/JNEUROSCI.2513-15.2016","volume":"36","author":"JW Goodliffe","year":"2016","unstructured":"Goodliffe JW, Olmos-Serrano JL, Aziz NM et al (2016) Absence of prenatal forebrain defects in the Dp(16)1Yey\/+ mouse model of Down Syndrome. J Neurosci 36:2926\u20132944. https:\/\/doi.org\/10.1523\/JNEUROSCI.2513-15.2016","journal-title":"J Neurosci"},{"key":"5245_CR25","doi-asserted-by":"publisher","first-page":"114323","DOI":"10.1016\/j.physbeh.2023.114323","volume":"271","author":"TG Glass","year":"2023","unstructured":"Glass TG, Lenell C, Fisher EH, Yang Q, Connor NP (2023) Ultrasonic vocalization phenotypes in the Ts65Dn and dp(16)1Yey mouse models of Down syndrome. Physiol Behav 271:114323. https:\/\/doi.org\/10.1016\/j.physbeh.2023.114323","journal-title":"Physiol Behav"},{"key":"5245_CR26","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.neubiorev.2008.08.003","volume":"33","author":"ML Scattoni","year":"2009","unstructured":"Scattoni ML, Crawley J, Ricceri L (2009) Ultrasonic vocalizations: a tool for behavioural phenotyping of mouse models of neurodevelopmental disorders. Neurosci Biobehav Rev 33:508\u2013515. https:\/\/doi.org\/10.1016\/j.neubiorev.2008.08.003","journal-title":"Neurosci Biobehav Rev"},{"key":"5245_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.expneurol.2013.10.018","volume":"251","author":"P Bianchi","year":"2014","unstructured":"Bianchi P, Bettini S, Guidi S et al (2014) Age-related impairment of olfactory bulb neurogenesis in the Ts65Dn mouse model of Down syndrome. Exp Neurol 251:1\u201311. https:\/\/doi.org\/10.1016\/j.expneurol.2013.10.018","journal-title":"Exp Neurol"},{"key":"5245_CR28","doi-asserted-by":"publisher","first-page":"812","DOI":"10.2174\/1871527315666160801143108","volume":"16","author":"S Guidi","year":"2017","unstructured":"Guidi S, Bianchi P, Stagni F et al (2017) Lithium restores Age-related olfactory impairment in the Ts65Dn mouse model of Down Syndrome. CNS Neurol Disord Drug Targets 16:812\u2013819. https:\/\/doi.org\/10.2174\/1871527315666160801143108","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"5245_CR29","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/s0197-4580(01)00263-9","volume":"23","author":"RK Nijjar","year":"2002","unstructured":"Nijjar RK, Murphy C (2002) Olfactory impairment increases as a function of age in persons with Down syndrome. Neurobiol Aging 23:65\u201373. https:\/\/doi.org\/10.1016\/s0197-4580(01)00263-9","journal-title":"Neurobiol Aging"},{"key":"5245_CR30","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1002\/ajmg.a.37156","volume":"167A","author":"F Guedj","year":"2015","unstructured":"Guedj F, Pennings JLA, Ferres MA et al (2015) The fetal brain transcriptome and neonatal behavioral phenotype in the Ts1Cje mouse model of Down syndrome. Am J Med Genet A 167A:1993\u20132008. https:\/\/doi.org\/10.1002\/ajmg.a.37156","journal-title":"Am J Med Genet A"},{"key":"5245_CR31","doi-asserted-by":"publisher","first-page":"13333","DOI":"10.1073\/pnas.93.23.13333","volume":"93","author":"DM Holtzman","year":"1996","unstructured":"Holtzman DM, Santucci D, Kilbridge J et al (1996) Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome. Proc Natl Acad Sci U S A 93:13333\u201313338. https:\/\/doi.org\/10.1073\/pnas.93.23.13333","journal-title":"Proc Natl Acad Sci U S A"},{"key":"5245_CR32","doi-asserted-by":"publisher","first-page":"dmm049721","DOI":"10.1242\/dmm.049721","volume":"15","author":"A Duchon","year":"2022","unstructured":"Duchon A, Del Mar Mu\u00f1iz Moreno M, Chevalier C et al (2022) Ts66Yah, a mouse model of Down syndrome with improved construct and face validity. Dis Model Mech 15:dmm049721. https:\/\/doi.org\/10.1242\/dmm.049721","journal-title":"Dis Model Mech"},{"issue":"23","key":"5245_CR33","doi-asserted-by":"publisher","first-page":"00086","DOI":"10.1016\/j.biopsych.2023.02.012","volume":"S0006\u20133223","author":"F Guedj","year":"2023","unstructured":"Guedj F, Kane E, Bishop LA et al (2023) The impact of Mmu17 Non-Hsa21 orthologous genes in the Ts65Dn mouse model of Down Syndrome: the Gold Standard refuted. Biol Psychiatry S0006\u20133223(23):00086\u201300080. https:\/\/doi.org\/10.1016\/j.biopsych.2023.02.012","journal-title":"Biol Psychiatry"},{"key":"5245_CR34","doi-asserted-by":"publisher","first-page":"4016","DOI":"10.1038\/s41598-022-08064-9","volume":"12","author":"KA Ambro\u017ckiewicz","year":"2022","unstructured":"Ambro\u017ckiewicz KA, Koz\u0142owska U, Haesler V et al (2022) Murine glial progenitor cells transplantation and synthetic PreImplantation factor (sPIF) reduces inflammation and early motor impairment in ALS mice. Sci Rep 12:4016. https:\/\/doi.org\/10.1038\/s41598-022-08064-9","journal-title":"Sci Rep"},{"key":"5245_CR35","doi-asserted-by":"publisher","first-page":"8769","DOI":"10.1523\/JNEUROSCI.0534-10.2010","volume":"30","author":"P Bianchi","year":"2010","unstructured":"Bianchi P, Ciani E, Guidi S et al (2010) Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome. J Neurosci 30:8769\u20138779. https:\/\/doi.org\/10.1523\/JNEUROSCI.0534-10.2010","journal-title":"J Neurosci"},{"key":"5245_CR36","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/brain\/awt340","volume":"137","author":"S Guidi","year":"2014","unstructured":"Guidi S, Stagni F, Bianchi P et al (2014) Prenatal pharmacotherapy rescues brain development in a down\u2019s syndrome mouse model. Brain 137:380\u2013401. https:\/\/doi.org\/10.1093\/brain\/awt340","journal-title":"Brain"},{"key":"5245_CR37","doi-asserted-by":"publisher","first-page":"105694","DOI":"10.1016\/j.nbd.2022.105694","volume":"168","author":"MM Ahmed","year":"2022","unstructured":"Ahmed MM, Wang AC-J, Elos M et al (2022) The innate immune system stimulating cytokine GM-CSF improves learning\/memory and interneuron and astrocyte brain pathology in Dp16 Down syndrome mice and improves learning\/memory in wild-type mice. Neurobiol Dis 168:105694. https:\/\/doi.org\/10.1016\/j.nbd.2022.105694","journal-title":"Neurobiol Dis"},{"key":"5245_CR38","doi-asserted-by":"publisher","first-page":"116098","DOI":"10.1016\/j.ejmech.2023.116098","volume":"265","author":"JM Delabar","year":"2024","unstructured":"Delabar JM, Gomes MAGB, Fructuoso M et al (2024) EGCG-like non-competitive inhibitor of DYRK1A rescues cognitive defect in a down syndrome model. Eur J Med Chem 265:116098","journal-title":"Eur J Med Chem"},{"key":"5245_CR39","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/hipo.20308","volume":"17","author":"A Contestabile","year":"2007","unstructured":"Contestabile A, Fila T, Ceccarelli C et al (2007) Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with Down syndrome and in Ts65Dn mice. Hippocampus 17:665\u2013678. https:\/\/doi.org\/10.1002\/hipo.20308","journal-title":"Hippocampus"},{"key":"5245_CR40","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.4161\/cc.29104","volume":"13","author":"U Soppa","year":"2014","unstructured":"Soppa U, Schumacher J, Florencio Ortiz V et al (2014) The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and cyclin D1 and induces cell cycle exit and neuronal differentiation. Cell Cycle 13:2084\u20132100. https:\/\/doi.org\/10.4161\/cc.29104","journal-title":"Cell Cycle"},{"key":"5245_CR41","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/cercor\/bhx356","volume":"29","author":"J-L Chen","year":"2019","unstructured":"Chen J-L, Chang C-H, Tsai J-W (2019) Gli2 rescues delays in Brain Development Induced by Kif3a Dysfunction. Cereb Cortex 29:751\u2013764. https:\/\/doi.org\/10.1093\/cercor\/bhx356","journal-title":"Cereb Cortex"},{"key":"5245_CR42","doi-asserted-by":"publisher","first-page":"106359","DOI":"10.1016\/j.nbd.2023.106359","volume":"190","author":"LE Hawley","year":"2023","unstructured":"Hawley LE, Stringer M, Deal AJ et al (2023) Sex-specific developmental alterations in DYRK1A expression in the brain of a Down syndrome mouse model. Neurobiol Dis 190:106359. https:\/\/doi.org\/10.1016\/j.nbd.2023.106359","journal-title":"Neurobiol Dis"},{"key":"5245_CR43","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1038\/ejhg.2015.71","volume":"23","author":"JJ Li","year":"2015","unstructured":"Li JJ, Lee H, Argiropoulos B (2015) DYRK1A haploinsufficiency causes a new recognizable syndrome with microcephaly, intellectual disability, speech impairment, and distinct facies. Eur J Hum Genet 23:1473\u20131481. https:\/\/doi.org\/10.1038\/ejhg.2015.71Epub 2015 May 6","journal-title":"Eur J Hum Genet"},{"key":"5245_CR44","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.tins.2016.10.001","volume":"39","author":"PJ Yao","year":"2016","unstructured":"Yao PJ, Petralia RS, Mattson MP (2016) Sonic hedgehog signaling and hippocampal neuroplasticity. Trends Neurosci 39:840\u2013850. https:\/\/doi.org\/10.1016\/j.tins.2016.10.001","journal-title":"Trends Neurosci"},{"key":"5245_CR45","doi-asserted-by":"publisher","first-page":"794675","DOI":"10.3389\/fncel.2021.794675","volume":"15","author":"JA Klein","year":"2021","unstructured":"Klein JA, Li Z, Rampam S et al (2021) Sonic hedgehog pathway modulation normalizes expression of Olig2 in rostrally patterned NPCs with trisomy 21. Front Cell Neurosci 15:794675. https:\/\/doi.org\/10.3389\/fncel.2021.794675","journal-title":"Front Cell Neurosci"},{"key":"5245_CR46","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1111\/jcmm.17817","volume":"27","author":"G Postic","year":"2023","unstructured":"Postic G, Solarz J, Loubi\u00e8re C et al (2023) Over-expression of Dyrk1A affects bleeding by modulating plasma fibronectin and fibrinogen level in mice. J Cell Mol Med 27:2228\u20132238. https:\/\/doi.org\/10.1111\/jcmm.17817","journal-title":"J Cell Mol Med"},{"key":"5245_CR47","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/embr.201337424","volume":"15","author":"N Zinin","year":"2014","unstructured":"Zinin N, Adameyko I, Wilhelm M et al (2014) MYC proteins promote neuronal differentiation by controlling the mode of progenitor cell division. EMBO Rep 15:383\u2013391. https:\/\/doi.org\/10.1002\/embr.201337424","journal-title":"EMBO Rep"},{"key":"5245_CR48","doi-asserted-by":"publisher","first-page":"9445","DOI":"10.1523\/JNEUROSCI.0011-11.2011","volume":"31","author":"JA Troca-Mar\u00edn","year":"2011","unstructured":"Troca-Mar\u00edn JA, Alves-Sampaio A, Montesinos ML (2011) An increase in basal BDNF provokes hyperactivation of the akt-mammalian target of Rapamycin Pathway and Deregulation of local dendritic translation in a mouse model of Down\u2019s syndrome. J Neurosci 31:9445\u20139455. https:\/\/doi.org\/10.1523\/JNEUROSCI.0011-11.2011","journal-title":"J Neurosci"},{"key":"5245_CR49","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s12035-012-8284-7","volume":"46","author":"A Tlili","year":"2012","unstructured":"Tlili A, Hoischen A, Ripoll C et al (2012) BDNF and DYRK1A are variable and inversely correlated in Lymphoblastoid Cell lines from Down Syndrome patients. Mol Neurobiol 46:297\u2013303. https:\/\/doi.org\/10.1007\/s12035-012-8284-7","journal-title":"Mol Neurobiol"},{"key":"5245_CR50","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/s0028-3908(98)00141-5","volume":"37","author":"W Pan","year":"1998","unstructured":"Pan W, Banks WA, Fasold MB et al (1998) Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37:1553\u20131561. https:\/\/doi.org\/10.1016\/s0028-3908(98)00141-5","journal-title":"Neuropharmacology"},{"key":"5245_CR51","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.neuron.2020.09.010","volume":"108","author":"B Pinto","year":"2020","unstructured":"Pinto B, Morelli G, Rastogi M et al (2020) Rescuing over-activated Microglia restores cognitive performance in Juvenile animals of the Dp(16) mouse model of Down Syndrome. Neuron 108:887\u2013904e12. https:\/\/doi.org\/10.1016\/j.neuron.2020.09.010","journal-title":"Neuron"},{"key":"5245_CR52","doi-asserted-by":"publisher","first-page":"239821282097804","DOI":"10.1177\/2398212820978049","volume":"4","author":"EG Dutcher","year":"2020","unstructured":"Dutcher EG, Pama EAC, Lynall M-E et al (2020) Early-life stress and inflammation: a systematic review of a key experimental approach in rodents. Brain Neurosci Adv 4:2398212820978049. https:\/\/doi.org\/10.1177\/2398212820978049","journal-title":"Brain Neurosci Adv"},{"key":"5245_CR53","doi-asserted-by":"publisher","first-page":"e0232493","DOI":"10.1371\/journal.pone.0232493","volume":"15","author":"M Spinelli","year":"2020","unstructured":"Spinelli M, Boucard C, Di Nicuolo F et al (2020) Synthetic PreImplantation factor (sPIF) reduces inflammation and prevents preterm birth. PLoS ONE 15:e0232493. https:\/\/doi.org\/10.1371\/journal.pone.0232493","journal-title":"PLoS ONE"},{"key":"5245_CR54","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.brainres.2016.06.003","volume":"1646","author":"N Creau","year":"2016","unstructured":"Creau N, Cabet E, Daubigney F, Souchet B, Bennai S, Delabar J (2016) Specific age-related molecular alterations in the cerebellum of Down syndrome mouse models. Brain res 1646:342\u2013353. https:\/\/doi.org\/10.1016\/j.brainres.2016.06.003Epub 2016 Jun 11","journal-title":"Brain res"},{"key":"5245_CR55","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3109\/08958378.2014.970786","volume":"26","author":"T Gawlikowski","year":"2014","unstructured":"Gawlikowski T, Golasik M, Gom\u00f3\u0142ka E, Piekoszewski W (2014) Proteins as biomarkers of carbon monoxide neurotoxicity. Inhal Toxicol 26:885\u2013890. https:\/\/doi.org\/10.3109\/08958378.2014.970786","journal-title":"Inhal Toxicol"},{"key":"5245_CR56","doi-asserted-by":"publisher","first-page":"dmm035634","DOI":"10.1242\/dmm.035634","volume":"11","author":"TL Nguyen","year":"2018","unstructured":"Nguyen TL, Duchon A, Manousopoulou A et al (2018) Correction of cognitive deficits in mouse models of Down syndrome by a pharmacological inhibitor of DYRK1A. Dis Model Mech 11:dmm035634. https:\/\/doi.org\/10.1242\/dmm.035634","journal-title":"Dis Model Mech"},{"key":"5245_CR57","doi-asserted-by":"publisher","first-page":"3914","DOI":"10.1038\/s41598-019-40328-9","volume":"9","author":"B Souchet","year":"2019","unstructured":"Souchet B, Duchon A, Gu Y et al (2019) Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models. Sci Rep 9:3914. https:\/\/doi.org\/10.1038\/s41598-019-40328-9","journal-title":"Sci Rep"},{"key":"5245_CR58","doi-asserted-by":"publisher","unstructured":"Tramutola A, Lanzillotta C, Aceto G et al (2023) Intranasal Administration of KYCCSRK Peptide Rescues Brain Insulin Signaling Activation and Reduces Alzheimer\u2019s Disease-like Neuropathology in a Mouse Model for Down Syndrome. Antioxidants 2023, 12(1), 111; https:\/\/doi.org\/10.3390\/antiox12010111","DOI":"10.3390\/antiox12010111"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05245-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-024-05245-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-024-05245-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T10:05:07Z","timestamp":1715594707000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-024-05245-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,13]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["5245"],"URL":"https:\/\/doi.org\/10.1007\/s00018-024-05245-9","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,13]]},"assertion":[{"value":"19 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All animal experiments were performed in accordance with the criteria in the European Communities Council Directive (86\/609\/EEC). Animal use and procedures were approved by an independent ethics committee at Universit\u00e9 Paris Cit\u00e9, CEEA-121 Paris-Nord, and the French Ministry of Research (approval references: #26966-2020061421099596 and #33486-2021101816069050).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable: the study did not involve human participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable: the manuscript does not contain personal data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"215"}}